| Today's Open | $7.99 |
|---|---|
| Previous Close | $7.94 |
| Daily Range | $7.87 - $8.20 |
| 52-Week Range | $1.55 - $9.98 |
| Market Cap | $657.8M |
| P/E Ratio | -30.54 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,392,027 |
| Average Daily Volume | 2,693,771 |
| Current FY EPS | -$0.32 |
Sector
Healthcare
Industry
Drugs
Keryx Biopharmaceuticals (KERX) Description
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website: http://www.keryx.com/
News & Commentary
Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials
Results? Yes. Starting them? Not so much.Is Keryx Biopharmaceuticals Burning Too Much Cash?
What is Keryx's burn rate, and how much cash does it have on hand?KERX's Top Competitors
(1.39%)
(2.02%)
(0.31%)
(1.31%)